These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
18. In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance. Lei F; Zhao B; Haque R; Xiong X; Budgeon L; Christensen ND; Wu Y; Song J Cancer Res; 2011 Jul; 71(14):4742-7. PubMed ID: 21628492 [TBL] [Abstract][Full Text] [Related]
19. [Cancer vaccine therapy using genetically modified induced pluripotent stem cell-derived dendritic cells expressing the TAA gene]. Iwamoto H; Ojima T; Nakamori M; Nakamura M; Hayata K; Katsuda M; Iida T; Miyazawa M; Iwahashi M; Yamaue H Gan To Kagaku Ryoho; 2013 Nov; 40(12):1575-7. PubMed ID: 24393853 [TBL] [Abstract][Full Text] [Related]
20. Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions. Su Z; Frye C; Bae KM; Kelley V; Vieweg J Clin Cancer Res; 2008 Oct; 14(19):6207-17. PubMed ID: 18829500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]